// 總部位於深圳的AI藥物研發公司Xtalpi於週二宣布，與美國製藥巨頭Eli Lilly達成了一項價值高達2.5億美元的合作協議，旨在發現尚未公開的疾病的潛在藥物。
Shenzhen-based Xtalpi, an AI-powered drug discoverer, announced Tuesday it has partnered with U.S. pharmaceutical giant Eli Lilly in a deal worth up to $250 million to unearth potential medicines for an undisclosed disease. https://www.forbes.com/sites/zinnialee/2023/05/30/sequoia-china-backed-ai-startup-xtalpi-to-partner-with-pharma-giant-eli-lilly-in-250-million-novel-drug-deal/ //